Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 7Lymphoma 7Lymphoma, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Hairy Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Hematologic Diseases 2Sezary Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Cytokine Release Syndrome 1Burkitt Lymphoma 1

Interventions

Rituximab 3Diphenhydramine 2Bendamustine Hydrochloride 2Acetaminophen 2obinutuzumab 1immunotoxin HA22 1ibrutinib 1fludarabine phosphate 1Vemurafenib 1Valganciclovir 1Therapeutics 1Specimen Handling 1Sodium Chloride 1Polymerase Chain Reaction 1Pentostatin 1Magnetic Resonance Imaging 1Histamine Antagonists 1High-Energy Shock Waves 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Famotidine 1Exercise Test 1Etoposide 1Epinephrine 1Electrocardiography 1Echocardiography 1Dexamethasone 1Cyclophosphamide 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Hairy Cell × Bendamustine Hydrochloride × Clear all
NCT02153580 2025-10-06

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
37 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Hairy Cell, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

NCT01059786 2025-06-12

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
69 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Hairy Cell, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡